Form 4 Revolution Medicines, For: Jun 20 Filed by: Borisy Alexis
Revolution Medicines, Inc. (RVMD)
Company Research
Source: SEC EDGAR
Impact Snapshot
Event Time:
RVMD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RVMD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RVMD alerts
High impacting Revolution Medicines, Inc. news events
Weekly update
A roundup of the hottest topics
RVMD
News
- Revolution Medicines, Inc. (NASDAQ: RVMD) had its price target raised by analysts at Barclays PLC from $54.00 to $60.00. They now have an "overweight" rating on the stock.MarketBeat
- Revolution Medicines: It's Full Steam Ahead, But I Wouldn't Buy At These Levels [Seeking Alpha]Seeking Alpha
- Revolution Medicines, Inc. (NASDAQ: RVMD) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $56.00 price target on the stock.MarketBeat
- Revolution Medicines, Inc. (NASDAQ: RVMD) had its price target lowered by analysts at JPMorgan Chase & Co. from $55.00 to $54.00. They now have an "overweight" rating on the stock.MarketBeat
- Revolution Medicines, Inc. (NASDAQ: RVMD) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $59.00 price target on the stock.MarketBeat
RVMD
Earnings
- 8/7/24 - Miss
RVMD
Sec Filings
- 9/18/24 - Form 4
- 9/18/24 - Form 4
- 9/18/24 - Form 4
- RVMD's page on the SEC website